The Lancet Neurology in conversation with
The Lancet Neurology in conversation with
The Lancet Group
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's
27 minutes Posted Apr 6, 2022 at 1:00 pm.
0:00
27:15
Download MP3
Show notes

Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.